INDUSTRY INSIGHTS YOUR PEERS ARE READING
After signing a groundbreaking deal with cosmetics company L’Oreal for the development of 3D printed skin for cosmetics testing, Organovo continues to make partners in powerful places. By Michael Molitch-Hou. MORE
Californian bioprinting company Organovo has announced a collaboration with the University of Virginia to utilize bioprinting technology to treat volumetric muscle loss (VML). Christ Eric David Organovo Organovo University of Virginia University of Virginia VML Volumetric Muscle LossWhat is volumetric muscle loss? Volumetric muscle. Medical & Dental bioprinting bioprinting muscle Dr. Christ Dr. George J. MORE
That’s also why bioprinting firm Organovo has today announced that the launch of their subsidiary Samsara Sciences, Inc., … The original post Organovo’s Samsara to Sell Liver Cells for Bioprinting appeared first on 3D Printing Industry. By Michael Molitch-Hou. MORE
3D bioprinting materials company Organovo (NASDAQ:ONVO) has announced that it is exploring “strategic alternatives” for its business after deciding that its liver tissue requires redevelopment. Business Organovo Taylor J. California-based private investment banking firm Roth Capital Partners has been engaged as the company’s financial adviser as it pursues its options. “After a rigorous assessment of our liver therapeutic tissue program, we’ve […]. MORE
This edition of 3D printing news Sliced features stories from Praxair, MyMiniFactory, XJet, citim, TechniPlas, DWS, Viscient Biosciences, Organovo, BioBots, Allevi, Innovate UK, Iterate Design, 3DMAC, Walter Reed National Military Medical Center, Formlabs, ArandaLasch, and the University of Tennessee. MORE
Organovo (NYSE MKT:ONVO) is one of those companies which seems to be almost too ahead of their time to really be taken seriously from an investment standpoint. 3D Printing Business (NYSE MKT:ONVO) exVive3D onvo earnings onvo stock organovo 2015 organovo earningsThat’s at least the feeling I get when discussing... View the entire article via our website. MORE
If you hold shares of Organovo stock (NYSE MKT: ONVO), then you know that the past 18 months have been a rollercoaster ride. 3D Printing Business bioprinting ONVO onvo stock organovo organovo earnings Shares of the stock have bounced between $12.50 in late 2013,... View the entire article via our website. MORE
3D Printing Business 3d printing stocks NYSEMKT: ONVO ONVO onvo stock organovo organovo secondary offering organovo stockIf you are an investor, particularly within the 3D printing space, then you know that it often takes nerves of steel to not panic when the stocks you own seem to be on a... View the entire article via our website. MORE
3D Printing Health 3D Printing 3d bioprinting 3d printed human tissue 3d printed kidney bioprinted organs bioprinting drug testing exVive3D kidney NovoGen NYSE: ONVO ONVO organovo pharmaceuticals printed kidney tissue Bioprinting is in our future. No longer the stuff of sci-fi dreams, the technology is taking a true hold in today’s world — and even in the dictionary. By bringing 3D printing together with... View the entire article via our website. MORE
3D Printing 3D Printing Materials Business Medical 3D Printing 3D Bioprinted Human Liver Tissue 3d bioprinting 3d bioprinting 3d print tissue bioprinting bioprinting research clinical trials 3d print exVive 3D Human Liver Tissue liver transplants medical 3d printing medical research NovoGen Bioprinter organovo Samsara Sciences MORE
Companies like San Diego-based Organovo (NYSE: ONVO) are making substantial progress within the area of 3D bioprinting, allowing for... View the entire article via our website. Without a doubt, the most exciting applications for 3D printing, reside within the medical field. MORE
The name Organovo is one that instantly commands admiration, if not awe, from anyone familiar with it. 3D Printing Business Medical 3D Printing 3d bioprinting 3d printed kidney 3D printed kidney tissue 3d printed tissue bioprinting exVive 3D Human Liver Tissue exVive3D Melissa Little Methuselah Foundation Murdoch Childrens Research Institute organovo organovo kidney Royal Children's Hospital MORE
As Organovo leads in the realm of 3D printed human tissue, it’s no surprise to see that revenues are up once again—and substantially so. 3D Printing Business Medical 3D Printing 3D printed kidney tissue 3d printed liver tissue 3d printed organs 3d printed tissue bioprinting financial report ONVO onvo earnings onvo stock organovo organovo earnings organovo stock Q3 2017 fiscal results Organovo MORE
3D Printers 3D Printing Bioprinting Medical 3D Printing 3d printing tissue exVive 3D Human Liver Tissue liver disease merck NovoGen Bioprinter organ transplant organovo Samsara Sciences tissue engineeringRemember when movies like The Island seemed like a scary yet foreseeable future? In 2005, the sci-fi thriller introduced a compound inhabited by clones used for organ harvesting, as well as. View the entire article via our website. MORE
Management changes across the 3D printing industry continue in 2017 as 3D bioprinting company Organovo Holdings, Inc. Business 3D Bioprinting Dr. Kirk Malloy eStudySite Keith Murphy Kirk Malloy Organovo regenerative medicine Taylor Crouch Taylor J. NASDAQ:ONVO) has announces Keith Murphy will be stepping down as CEO. Crouch tissue engineering MORE
You all probably know by now that Organovo (NYSE: ONVO) is leading the charge when it comes to 3D printing organ tissue. 3D Printing Business Health 3D Printing 3d printed human tissue 3d printed skin collaboration l''oreal usa NovoGen NYSE: ONVO ONVO organovo organovo collaboration organovo L''oreal organovo stock partnership research MORE
Pioneer bioprinting company Organovo presented new findings in their stem-cell-based approach to developing kidney tissue using its 3D bioprinting platform, the NovoGen Bioprinter. 3D Printers 3D Printing Bioprinting Medical 3D Printing ExVive 3D Human Kidney Tissue kidney tissue Murdoch Childrens Research Institute NovoGen Bioprinter organovo renal disease The International Society for Stem Cell Research MORE
Following a demand for tissue development research, 3D bioprinting material provider Organovo (NASDAQ:ONVO) has reported a total revenue of $1.0 Business 3D Bioprinting bioprinting Organovo stem cell research stem cells Taylor J. million for the first quarter of FY 2018, an 11% increase on the same period in 2017. With the results, the company also affirms its outlook for the full-year, expecting total revenue to reach $6.0 million – […]. MORE
Are you wondering how you can use 3D printing to customize your sleek new Crocs? Or, maybe is there anything you can 3D print to make Mario Kart victory laps even sweeter? On a more serious note, what does forensic science hold for the future of 3D printing? MORE
Though Organovo produced 3D printed kidney cells earlier this year, last week, Professor Melissa Little‘s research team at the University of Queensland (UQ)’s Institute for Molecular Bioscience demonstrated the ability to create a complete miniature kidney. By Michael Molitch-Hou. MORE
Organovo (NASDAQ:ONVO) shares fell in response to a financing update yesterday: the company received a 15% hit to its stock price during NASDAQ trading. bodyTop Medical & Dental 3D Bioprinting bioprinting kidney l'oreal liver Organovo MORE
While many have claimed–perhaps a bit too ambitiously–that 3D printing will change the world, Organovo is an undeniable example of a company poised to change the world in their niche. 3D Printing Business Health 3D Printing 3d printed liver cells 3D printing cellular structures bioprinting kidney tissue organovo organovo kidney organovo L'oreal organovo liver Popular Science Magazine MORE
L’Oreal USA, the largest subsidiary of the world’s leading beauty company, has announced a partnership with 3-D bioprinting company Organovo Holdings, Inc. (“Organovo”). MORE
3D bio-printing company, Organovo (NASDAQ:ONVO) have reported revenue for the quarter ended September 30, 2016. Stock Market OrganovoAccording to unaudited information filed with the Securities and Exchange. MORE
There are so many areas within the 3D printing space one can get excited about; however, in my opinion one of the most exciting areas is the work being done by San Diego-based Organovo,... View the entire article via our website. MORE
3D Printing Business Health 3D Printing (NYSE:ONVO) exVive3D merch mrk NYSE: MRK ONVO onvo stock organovo merck organovo research partnership organovo stock The 3D bioprinting space may be about to take off in a big way. As investment dollars flow into companies seeking to transform medicine via the 3D printing of biological material, innovated new approaches... View the entire article via our website. MORE
Just after announcing the successful 3D printing of kidney cells, bioprinting firm Organovo has decided to add 3D printed skin to its portfolio of printable organ tissues. While the agreement gives L’Oreal exclusive rights to the models for use in the R&D and production of its own non-prescription beauty and skin care products, Organovo can still sell its skin tissues for use in pharmaceutical testing, therapy, and surgical transplants. By Michael Molitch-Hou. MORE
Organovo (NASDAQ:ONVO) the 3D bioprinting company with headquarters in San Diego, CA have reported annual revenue of $1.5 million for fiscal 2016. Total product and. Stock Market MORE
Organovo (NASDAQ: ONVO), the first company to market 3D bioprinting technology, has announced the sale of its bioprinted livers, called the exVive3D™ Liver Model. By Michael Molitch-Hou. In some ways, today may be a day looked back on as a turning point in medical history. MORE
Organovo is one of the most fascinating companies that we follow–and quite continually–as the dynamic company has kept the momentum rolling with one scientific breakthrough after another. 3D Printing Business Health 3D Printing 3d bioprinting 3d printed kidney 3d printing partnership bioprinting kidney tissue organovo organovo kidney organovo research partnership printed kidney tissue Uniquest MORE
As we’ve mentioned in the past, the rollercoaster ride, known all too well to Organovo (NYSEMKT: ONVO) shareholders, has been quite bumpy. 3D Printing Business Health 3D Printing 3d print cancer 3d printed kidney 3d printed liver 3d printing stocks NYSEMKT: ONVO ONVO onvo stock organovo organovo future organovo kidney organovo secondary offering MORE
And although his vision for Organovo‘s... View the entire article via our website. 3D Printing Business Health 3D Printing 3d bioprinting bioprinting L'Oreal merck ONVO onvo stock organovo organovo stock yaleEven before meeting Keith Murphy for the first time at an Inside 3D Printing Event last year I had been a big fan of the San Diego-based company. MORE
When it comes to 3D printing human tissue, Organovo (ONVO) is leading the charge. 3D Printing Business 2016 q1 onvo exVive3D onvo earnings onvo stock organovo 2016 earnings organovo earnings organovo stockWhile the company’s stock has floundered as of late, dropping to as low as $2.78 last week, they continue to... View the entire article via our website. MORE
Organovo has already made breakthroughs in 3D bioprinting, releasing the first commercial array of liver cells for pharmaceutical testing just last month. Thanks to a gift from the Methuselah Foundation, Organovo is partnering with the Department of Surgery at Yale School of Medicine to develop bioprinted tissues for surgical transplantation research.… … The original post Organovo & Yale to Begin 3D Bioprinted Organ Research appeared first on 3D Printing Industry. MORE
Organovo CEO Keith Murphy came to the Q2 (FY 2017) analyst and investor call knowing that he would be on the receiving end of some. Stock Market Ardea Biosciences AstraZeneca ExVive Keith Murphy La Jolla Pharmaceutical Organovo Samsara MORE
Earlier this month, both Organovo and Viscient Biosciences announced their intent to collaborate on research for further studies into liver disease. 3D Printing Business Medical 3D Printing 3d bioprinting 3d printed liver tissue 3d printed tissue bioprinting ExVive organovo Viscient BiosciencesThere have been many interesting stories about. View the entire article via our website. MORE
3D Printing Health 3D Printing (NYSE MKT: ONVO) 3d printed liver 3d printed liver tissue 3d printed tissue exVive3D ONVO organovo New technologies such as 3D bioprinting promise to offer a laundry list of new treatments, drug discovery, and cures within the medical industry. MORE
Organovo is steadily on track with its organ bioprinting research. At the 2015 Experimental Biology conference in Boston, today, Organovo gave attendees a look at the work done so far on their in vitro three-dimensional kidney tissue. By Michael Molitch-Hou. MORE
Speculation on 3D printed tissue coming to humans sooner than we think is backed by new pre-clinical findings from 3D bioprinting company Organovo (NASDAQ:ONVO). Medical & Dental 3D Bioprinting cosmo bio FDA liver Organovo preclinical trials stem cell researchThough. MORE
Organovo is a well-known company to anyone involved in 3D printing, tissue engineering or both. 3D Printing Business Medical 3D Printing Science & Technology 3d bioprinting 3d printed liver 3d printed liver tissue Alpha-one-antitrypsin deficiency bioprinting exVive 3D Human Liver Tissue exVive3D fda approval fda regulations organovo US Food and Drug Administration World Advanced Therapies and Regenerative Medicine Congress MORE
Organovo Holdings, Inc. 3D Printing Business Health 3D Printing 3d bioprinting DiscoveRcx keith murphy L'Oreal medical 3d printing organovo Paul Gallanthas made waves with their ability to deliver scientific and medical breakthroughs via 3D bioprinting technology. The company’s 3D bioprinting methods enable the automated creation of living human tissues which mimic... View the entire article via our website. MORE
3D bioprinting company Organovo, (NASDAQ:ONVO) headquartered in San Diego, CA, has published an article showing successful 3D printing of the microscopic veins that make up a. Medical & Dental kidney kidney tubule lab-on-a-chip organ on a chip Organovo MORE
Interviewed Keith Murphy, Chairman and Chief Executive Officer of Organovo, a company known as the pioneer of 3D Bioprinting. Interview with Keith Murphy, Organovo appeared first on 3D Printing Industry. By 3DPI.TV. At the recent Inside 3D Printing Conference in Santa Clara, 3DPI.TV MORE
3D bioprinting leader Organovo has been steadily growing this year, signing deals with pharmaceutical giant Merck and cosmetics company L’Oreal, as well as releasing news related to their first 3D printed kidney tissue. By Michael Molitch-Hou. MORE
Organovo Related Topics 3D Printing Industry
NOVEMBER 3, 2016
3D bio-printing company, Organovo (NASDAQ:ONVO) have reported revenue for the quarter ended September 30, 2016. Stock Market OrganovoAccording to unaudited information filed with the Securities and Exchange.
3D Printing Industry
AUGUST 8, 2019
3D bioprinting materials company Organovo (NASDAQ:ONVO) has announced that it is exploring “strategic alternatives” for its business after deciding that its liver tissue requires redevelopment. Business Organovo Taylor J. California-based private investment banking firm Roth Capital Partners has been engaged as the company’s financial adviser as it pursues its options. “After a rigorous assessment of our liver therapeutic tissue program, we’ve […].
3D Printing Industry
MAY 2, 2017
Californian bioprinting company Organovo has announced a collaboration with the University of Virginia to utilize bioprinting technology to treat volumetric muscle loss (VML). Christ Eric David Organovo Organovo University of Virginia University of Virginia VML Volumetric Muscle LossWhat is volumetric muscle loss? Volumetric muscle. Medical & Dental bioprinting bioprinting muscle Dr. Christ Dr. George J.
3D Printing Industry
JUNE 17, 2019
Are you wondering how you can use 3D printing to customize your sleek new Crocs? Or, maybe is there anything you can 3D print to make Mario Kart victory laps even sweeter? On a more serious note, what does forensic science hold for the future of 3D printing?
3D Printing Industry
OCTOBER 21, 2016
Organovo (NASDAQ:ONVO) shares fell in response to a financing update yesterday: the company received a 15% hit to its stock price during NASDAQ trading. bodyTop Medical & Dental 3D Bioprinting bioprinting kidney l'oreal liver Organovo
3D Printing Industry
NOVEMBER 8, 2017
This edition of 3D printing news Sliced features stories from Praxair, MyMiniFactory, XJet, citim, TechniPlas, DWS, Viscient Biosciences, Organovo, BioBots, Allevi, Innovate UK, Iterate Design, 3DMAC, Walter Reed National Military Medical Center, Formlabs, ArandaLasch, and the University of Tennessee.
3DPrint.com
JULY 18, 2019
Pioneer bioprinting company Organovo presented new findings in their stem-cell-based approach to developing kidney tissue using its 3D bioprinting platform, the NovoGen Bioprinter. 3D Printers 3D Printing Bioprinting Medical 3D Printing ExVive 3D Human Kidney Tissue kidney tissue Murdoch Childrens Research Institute NovoGen Bioprinter organovo renal disease The International Society for Stem Cell Research
3D Printing Industry
NOVEMBER 4, 2016
Organovo CEO Keith Murphy came to the Q2 (FY 2017) analyst and investor call knowing that he would be on the receiving end of some. Stock Market Ardea Biosciences AstraZeneca ExVive Keith Murphy La Jolla Pharmaceutical Organovo Samsara
3DPrint.com
OCTOBER 13, 2015
Organovo is one of the most fascinating companies that we follow–and quite continually–as the dynamic company has kept the momentum rolling with one scientific breakthrough after another. 3D Printing Business Health 3D Printing 3d bioprinting 3d printed kidney 3d printing partnership bioprinting kidney tissue organovo organovo kidney organovo research partnership printed kidney tissue Uniquest
3D Printing Industry
OCTOBER 13, 2015
Though Organovo produced 3D printed kidney cells earlier this year, last week, Professor Melissa Little‘s research team at the University of Queensland (UQ)’s Institute for Molecular Bioscience demonstrated the ability to create a complete miniature kidney. By Michael Molitch-Hou.
3D Printing Industry
FEBRUARY 22, 2017
3D bioprinting company Organovo, (NASDAQ:ONVO) headquartered in San Diego, CA, has published an article showing successful 3D printing of the microscopic veins that make up a. Medical & Dental kidney kidney tubule lab-on-a-chip organ on a chip Organovo
3D Printing Industry
APRIL 12, 2017
Management changes across the 3D printing industry continue in 2017 as 3D bioprinting company Organovo Holdings, Inc. Business 3D Bioprinting Dr. Kirk Malloy eStudySite Keith Murphy Kirk Malloy Organovo regenerative medicine Taylor Crouch Taylor J. NASDAQ:ONVO) has announces Keith Murphy will be stepping down as CEO. Crouch tissue engineering
3D Printing Industry
DECEMBER 23, 2016
Speculation on 3D printed tissue coming to humans sooner than we think is backed by new pre-clinical findings from 3D bioprinting company Organovo (NASDAQ:ONVO). Medical & Dental 3D Bioprinting cosmo bio FDA liver Organovo preclinical trials stem cell researchThough.
3D Printing Industry
AUGUST 10, 2017
Following a demand for tissue development research, 3D bioprinting material provider Organovo (NASDAQ:ONVO) has reported a total revenue of $1.0 Business 3D Bioprinting bioprinting Organovo stem cell research stem cells Taylor J. million for the first quarter of FY 2018, an 11% increase on the same period in 2017. With the results, the company also affirms its outlook for the full-year, expecting total revenue to reach $6.0 million – […].
3DPrint.com
JUNE 29, 2015
As we’ve mentioned in the past, the rollercoaster ride, known all too well to Organovo (NYSEMKT: ONVO) shareholders, has been quite bumpy. 3D Printing Business Health 3D Printing 3d print cancer 3d printed kidney 3d printed liver 3d printing stocks NYSEMKT: ONVO ONVO onvo stock organovo organovo future organovo kidney organovo secondary offering
3DPrint.com
APRIL 7, 2015
You all probably know by now that Organovo (NYSE: ONVO) is leading the charge when it comes to 3D printing organ tissue. 3D Printing Business Health 3D Printing 3d printed human tissue 3d printed skin collaboration l''oreal usa NovoGen NYSE: ONVO ONVO organovo organovo collaboration organovo L''oreal organovo stock partnership research
3DPrint.com
NOVEMBER 19, 2015
While many have claimed–perhaps a bit too ambitiously–that 3D printing will change the world, Organovo is an undeniable example of a company poised to change the world in their niche. 3D Printing Business Health 3D Printing 3d printed liver cells 3D printing cellular structures bioprinting kidney tissue organovo organovo kidney organovo L'oreal organovo liver Popular Science Magazine
3D Printing Industry
FEBRUARY 9, 2017
Organovo (NASDAQ:ONVO) the 3D bioprinting company with headquarters in San Diego, CA have reported annual revenue of $1.5 million for fiscal 2016. Total product and. Stock Market
3DPrint.com
FEBRUARY 14, 2017
As Organovo leads in the realm of 3D printed human tissue, it’s no surprise to see that revenues are up once again—and substantially so. 3D Printing Business Medical 3D Printing 3D printed kidney tissue 3d printed liver tissue 3d printed organs 3d printed tissue bioprinting financial report ONVO onvo earnings onvo stock organovo organovo earnings organovo stock Q3 2017 fiscal results Organovo
3DPrint.com
AUGUST 11, 2015
When it comes to 3D printing human tissue, Organovo (ONVO) is leading the charge. 3D Printing Business 2016 q1 onvo exVive3D onvo earnings onvo stock organovo 2016 earnings organovo earnings organovo stockWhile the company’s stock has floundered as of late, dropping to as low as $2.78 last week, they continue to... View the entire article via our website.
3DPrint.com
JUNE 19, 2015
3D Printing Business 3d printing stocks NYSEMKT: ONVO ONVO onvo stock organovo organovo secondary offering organovo stockIf you are an investor, particularly within the 3D printing space, then you know that it often takes nerves of steel to not panic when the stocks you own seem to be on a... View the entire article via our website.
3D Printing Industry
APRIL 1, 2015
Organovo is steadily on track with its organ bioprinting research. At the 2015 Experimental Biology conference in Boston, today, Organovo gave attendees a look at the work done so far on their in vitro three-dimensional kidney tissue. By Michael Molitch-Hou.
3D Printing Industry
NOVEMBER 3, 2014
Interviewed Keith Murphy, Chairman and Chief Executive Officer of Organovo, a company known as the pioneer of 3D Bioprinting. Interview with Keith Murphy, Organovo appeared first on 3D Printing Industry. By 3DPI.TV. At the recent Inside 3D Printing Conference in Santa Clara, 3DPI.TV
3D Printing Review
MAY 19, 2015
L’Oreal USA, the largest subsidiary of the world’s leading beauty company, has announced a partnership with 3-D bioprinting company Organovo Holdings, Inc. (“Organovo”).
3D Printing Industry
JUNE 19, 2015
3D bioprinting leader Organovo has been steadily growing this year, signing deals with pharmaceutical giant Merck and cosmetics company L’Oreal, as well as releasing news related to their first 3D printed kidney tissue. By Michael Molitch-Hou.
3DPrint.com
APRIL 23, 2015
3D Printing Business Health 3D Printing (NYSE:ONVO) exVive3D merch mrk NYSE: MRK ONVO onvo stock organovo merck organovo research partnership organovo stock The 3D bioprinting space may be about to take off in a big way. As investment dollars flow into companies seeking to transform medicine via the 3D printing of biological material, innovated new approaches... View the entire article via our website.
3DPrint.com
JUNE 10, 2015
Organovo (NYSE MKT:ONVO) is one of those companies which seems to be almost too ahead of their time to really be taken seriously from an investment standpoint. 3D Printing Business (NYSE MKT:ONVO) exVive3D onvo earnings onvo stock organovo 2015 organovo earningsThat’s at least the feeling I get when discussing... View the entire article via our website.
3DPrint.com
APRIL 22, 2015
If you hold shares of Organovo stock (NYSE MKT: ONVO), then you know that the past 18 months have been a rollercoaster ride. 3D Printing Business bioprinting ONVO onvo stock organovo organovo earnings Shares of the stock have bounced between $12.50 in late 2013,... View the entire article via our website.
3D Printing Industry
NOVEMBER 18, 2014
Organovo (NASDAQ: ONVO), the first company to market 3D bioprinting technology, has announced the sale of its bioprinted livers, called the exVive3D™ Liver Model. By Michael Molitch-Hou. In some ways, today may be a day looked back on as a turning point in medical history.
3DPrint.com
SEPTEMBER 2, 2015
And although his vision for Organovo‘s... View the entire article via our website. 3D Printing Business Health 3D Printing 3d bioprinting bioprinting L'Oreal merck ONVO onvo stock organovo organovo stock yaleEven before meeting Keith Murphy for the first time at an Inside 3D Printing Event last year I had been a big fan of the San Diego-based company.
3DPrint.com
OCTOBER 5, 2016
3D Printing 3D Printing Materials Business Medical 3D Printing 3D Bioprinted Human Liver Tissue 3d bioprinting 3d bioprinting 3d print tissue bioprinting bioprinting research clinical trials 3d print exVive 3D Human Liver Tissue liver transplants medical 3d printing medical research NovoGen Bioprinter organovo Samsara Sciences
3DPrint.com
JANUARY 24, 2017
The name Organovo is one that instantly commands admiration, if not awe, from anyone familiar with it. 3D Printing Business Medical 3D Printing 3d bioprinting 3d printed kidney 3D printed kidney tissue 3d printed tissue bioprinting exVive 3D Human Liver Tissue exVive3D Melissa Little Methuselah Foundation Murdoch Childrens Research Institute organovo organovo kidney Royal Children's Hospital
3DPrint.com
AUGUST 8, 2015
Organovo Holdings, Inc. 3D Printing Business Health 3D Printing 3d bioprinting DiscoveRcx keith murphy L'Oreal medical 3d printing organovo Paul Gallanthas made waves with their ability to deliver scientific and medical breakthroughs via 3D bioprinting technology. The company’s 3D bioprinting methods enable the automated creation of living human tissues which mimic... View the entire article via our website.
3DPrint.com
DECEMBER 3, 2014
Companies like San Diego-based Organovo (NYSE: ONVO) are making substantial progress within the area of 3D bioprinting, allowing for... View the entire article via our website. Without a doubt, the most exciting applications for 3D printing, reside within the medical field.
3DPrint.com
OCTOBER 27, 2014
There are so many areas within the 3D printing space one can get excited about; however, in my opinion one of the most exciting areas is the work being done by San Diego-based Organovo,... View the entire article via our website.
3DPrint.com
NOVEMBER 22, 2017
Earlier this month, both Organovo and Viscient Biosciences announced their intent to collaborate on research for further studies into liver disease. 3D Printing Business Medical 3D Printing 3d bioprinting 3d printed liver tissue 3d printed tissue bioprinting ExVive organovo Viscient BiosciencesThere have been many interesting stories about. View the entire article via our website.
3D Printing Industry
APRIL 7, 2015
Just after announcing the successful 3D printing of kidney cells, bioprinting firm Organovo has decided to add 3D printed skin to its portfolio of printable organ tissues. While the agreement gives L’Oreal exclusive rights to the models for use in the R&D and production of its own non-prescription beauty and skin care products, Organovo can still sell its skin tissues for use in pharmaceutical testing, therapy, and surgical transplants. By Michael Molitch-Hou.
3DPrint.com
MAY 18, 2017
Organovo is a well-known company to anyone involved in 3D printing, tissue engineering or both. 3D Printing Business Medical 3D Printing Science & Technology 3d bioprinting 3d printed liver 3d printed liver tissue Alpha-one-antitrypsin deficiency bioprinting exVive 3D Human Liver Tissue exVive3D fda approval fda regulations organovo US Food and Drug Administration World Advanced Therapies and Regenerative Medicine Congress
3DPrint.com
APRIL 1, 2015
3D Printing Health 3D Printing 3d bioprinting 3d printed human tissue 3d printed kidney bioprinted organs bioprinting drug testing exVive3D kidney NovoGen NYSE: ONVO ONVO organovo pharmaceuticals printed kidney tissue Bioprinting is in our future. No longer the stuff of sci-fi dreams, the technology is taking a true hold in today’s world — and even in the dictionary. By bringing 3D printing together with... View the entire article via our website.
3D Printing Industry
DECEMBER 3, 2014
Organovo has already made breakthroughs in 3D bioprinting, releasing the first commercial array of liver cells for pharmaceutical testing just last month. Thanks to a gift from the Methuselah Foundation, Organovo is partnering with the Department of Surgery at Yale School of Medicine to develop bioprinted tissues for surgical transplantation research.… … The original post Organovo & Yale to Begin 3D Bioprinted Organ Research appeared first on 3D Printing Industry.
3D Printing Industry
JANUARY 13, 2016
That’s also why bioprinting firm Organovo has today announced that the launch of their subsidiary Samsara Sciences, Inc., … The original post Organovo’s Samsara to Sell Liver Cells for Bioprinting appeared first on 3D Printing Industry. By Michael Molitch-Hou.
3D Printing Industry
APRIL 23, 2015
After signing a groundbreaking deal with cosmetics company L’Oreal for the development of 3D printed skin for cosmetics testing, Organovo continues to make partners in powerful places. By Michael Molitch-Hou.
3DPrint.com
NOVEMBER 18, 2014
3D Printing Health 3D Printing (NYSE MKT: ONVO) 3d printed liver 3d printed liver tissue 3d printed tissue exVive3D ONVO organovo New technologies such as 3D bioprinting promise to offer a laundry list of new treatments, drug discovery, and cures within the medical industry.
114 
Let's personalize your content